EtectRx, Inc. is a Digital Health company having developed a ingestible event marker (ID-Cap System) designed to provide real-time, dose-level ingestion event verification. The ID-Cap System -- used by patients, healthcare providers, health systems, payers, and research organizations -- is designed to track ingestion events and to measure, monitor and improving medication adherence. It can also be used by pharmaceutical companies to develop Digital Medicine. classifed as a medical device. Cleared by FDA as an ingestible event marker, the system utilizes a proprietary in vivo communications technology that emits a very low power radio frequency (RF) digital message from within the patient after a sensor is ingested and detects the signal using a wearable Reader. Comprised of the ID-Capsule - containing the ingestible sensor (the ID-Tag) - the wearable ID-Cap Reader, and related software allows data to be displayed for patient and clinician. etectRx has successfully completed 14 IRB-approved clinical trials, including three NIH-sponsored trials, demonstrating the feasibility, effectiveness, and safety of the device
